FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2141750554> ?p ?o ?g. }

• W2141750554 endingPage "1646.e1" @default.
• W2141750554 startingPage "1639" @default.
• W2141750554 abstract "ObjectiveTo investigate the in vitro effects of atorvastatin on lipopolysaccharide (LPS)-induced gene expression in endometrial-endometriotic stromal cells.DesignIn vitro experimental study using flow cytometry, ELISA, semiquantitative reverse transcriptase polymerase chain reaction, and Western blot.SettingPostgraduate Institute of Medical Education and Research.Patient(s)Twenty-five women undergoing laparoscopy (n = 10) and laparotomy (n = 15).Intervention(s)Endometriotic cyst wall (group I) and endometrial biopsy (group II) collection.Main Outcome Measure(s)The endometrial-endometriotic stromal cells were isolated from ectopic (group I) and eutopic (group II) endometrium by established methods, cultured, and stimulated with LPS (1 μg/mL), followed by atorvastatin treatment in a time- and dose-dependent manner to investigate the effects of LPS on proliferation (Ki-67) and expression of cyclooxygenase-2 (COX-2), vascular endothelial growth factor (VEGF), receptor for advanced glycation end products (RAGE), extracellular newly identified RAGE binding protein (EN-RAGE), peroxisome proliferator activated receptor-γ (PPAR-γ), and liver X receptor-α (LXR-α) genes in endometrial-endometriotic stromal cells and on levels of insulin-like growth factor binding protein-1 (IGFBP-1) and 17β-E2 in endometrial-endometriotic stromal cell culture supernatant.Result(s)Significant inhibition of Ki-67 and LPS-induced expression of inflammatory and angiogenic genes (COX-2, VEGF, RAGE, and EN-RAGE) was observed in atorvastatin-treated endometrial-endometriotic stromal cells. In contrast, a significant dose- and time-dependent increase in expression of anti-inflammatory genes (PPAR-γ and LXR-α) and levels of IGFBP-1 was observed after atorvastatin treatment in both the groups. However, atorvastatin treatment had no effect on 17β-E2 levels in endometrial/endometriotic stromal cell culture supernatant.Conclusion(s)The data of the present study provide new insights for the implication of atorvastatin treatment for endometriosis in humans. To investigate the in vitro effects of atorvastatin on lipopolysaccharide (LPS)-induced gene expression in endometrial-endometriotic stromal cells. In vitro experimental study using flow cytometry, ELISA, semiquantitative reverse transcriptase polymerase chain reaction, and Western blot. Postgraduate Institute of Medical Education and Research. Twenty-five women undergoing laparoscopy (n = 10) and laparotomy (n = 15). Endometriotic cyst wall (group I) and endometrial biopsy (group II) collection. The endometrial-endometriotic stromal cells were isolated from ectopic (group I) and eutopic (group II) endometrium by established methods, cultured, and stimulated with LPS (1 μg/mL), followed by atorvastatin treatment in a time- and dose-dependent manner to investigate the effects of LPS on proliferation (Ki-67) and expression of cyclooxygenase-2 (COX-2), vascular endothelial growth factor (VEGF), receptor for advanced glycation end products (RAGE), extracellular newly identified RAGE binding protein (EN-RAGE), peroxisome proliferator activated receptor-γ (PPAR-γ), and liver X receptor-α (LXR-α) genes in endometrial-endometriotic stromal cells and on levels of insulin-like growth factor binding protein-1 (IGFBP-1) and 17β-E2 in endometrial-endometriotic stromal cell culture supernatant. Significant inhibition of Ki-67 and LPS-induced expression of inflammatory and angiogenic genes (COX-2, VEGF, RAGE, and EN-RAGE) was observed in atorvastatin-treated endometrial-endometriotic stromal cells. In contrast, a significant dose- and time-dependent increase in expression of anti-inflammatory genes (PPAR-γ and LXR-α) and levels of IGFBP-1 was observed after atorvastatin treatment in both the groups. However, atorvastatin treatment had no effect on 17β-E2 levels in endometrial/endometriotic stromal cell culture supernatant. The data of the present study provide new insights for the implication of atorvastatin treatment for endometriosis in humans." @default.
• W2141750554 created "2016-06-24" @default.
• W2141750554 creator A5052455152 @default.
• W2141750554 creator A5076070097 @default.
• W2141750554 creator A5081102298 @default.
• W2141750554 creator A5081227888 @default.
• W2141750554 creator A5081275337 @default.
• W2141750554 date "2010-10-01" @default.
• W2141750554 modified "2023-10-17" @default.
• W2141750554 title "In vitro effects of atorvastatin on lipopolysaccharide-induced gene expression in endometriotic stromal cells" @default.
• W2141750554 cites W1514451895 @default.
• W2141750554 cites W1534530371 @default.
• W2141750554 cites W1964923339 @default.
• W2141750554 cites W1971242943 @default.
• W2141750554 cites W1981689863 @default.
• W2141750554 cites W1984508574 @default.
• W2141750554 cites W1989877184 @default.
• W2141750554 cites W1997974115 @default.
• W2141750554 cites W2001822779 @default.
• W2141750554 cites W2017247290 @default.
• W2141750554 cites W2018923286 @default.
• W2141750554 cites W2020983524 @default.
• W2141750554 cites W2027604422 @default.
• W2141750554 cites W2030849425 @default.
• W2141750554 cites W2032287818 @default.
• W2141750554 cites W2035227348 @default.
• W2141750554 cites W2041563335 @default.
• W2141750554 cites W2049161944 @default.
• W2141750554 cites W2052583421 @default.
• W2141750554 cites W2053951615 @default.
• W2141750554 cites W2062605111 @default.
• W2141750554 cites W2070805231 @default.
• W2141750554 cites W2109525253 @default.
• W2141750554 cites W2117630250 @default.
• W2141750554 cites W2121772019 @default.
• W2141750554 cites W2123274778 @default.
• W2141750554 cites W2136879631 @default.
• W2141750554 cites W2143446059 @default.
• W2141750554 cites W2147203397 @default.
• W2141750554 cites W2153278559 @default.
• W2141750554 cites W2157528128 @default.
• W2141750554 cites W2159339965 @default.
• W2141750554 cites W2163678936 @default.
• W2141750554 cites W2166572585 @default.
• W2141750554 cites W2166604788 @default.
• W2141750554 cites W2607215535 @default.
• W2141750554 cites W4231488642 @default.
• W2141750554 cites W4240908764 @default.
• W2141750554 doi "https://doi.org/10.1016/j.fertnstert.2009.10.003" @default.
• W2141750554 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19944411" @default.
• W2141750554 hasPublicationYear "2010" @default.
• W2141750554 type Work @default.
• W2141750554 sameAs 2141750554 @default.
• W2141750554 citedByCount "33" @default.
• W2141750554 countsByYear W21417505542012 @default.
• W2141750554 countsByYear W21417505542013 @default.
• W2141750554 countsByYear W21417505542014 @default.
• W2141750554 countsByYear W21417505542015 @default.
• W2141750554 countsByYear W21417505542016 @default.
• W2141750554 countsByYear W21417505542017 @default.
• W2141750554 countsByYear W21417505542018 @default.
• W2141750554 countsByYear W21417505542019 @default.
• W2141750554 countsByYear W21417505542021 @default.
• W2141750554 countsByYear W21417505542022 @default.
• W2141750554 countsByYear W21417505542023 @default.
• W2141750554 crossrefType "journal-article" @default.
• W2141750554 hasAuthorship W2141750554A5052455152 @default.
• W2141750554 hasAuthorship W2141750554A5076070097 @default.
• W2141750554 hasAuthorship W2141750554A5081102298 @default.
• W2141750554 hasAuthorship W2141750554A5081227888 @default.
• W2141750554 hasAuthorship W2141750554A5081275337 @default.
• W2141750554 hasBestOaLocation W21417505541 @default.
• W2141750554 hasConcept C126322002 @default.
• W2141750554 hasConcept C134018914 @default.
• W2141750554 hasConcept C167734588 @default.
• W2141750554 hasConcept C16930146 @default.
• W2141750554 hasConcept C2777025900 @default.
• W2141750554 hasConcept C502942594 @default.
• W2141750554 hasConcept C71924100 @default.
• W2141750554 hasConcept C86803240 @default.
• W2141750554 hasConceptScore W2141750554C126322002 @default.
• W2141750554 hasConceptScore W2141750554C134018914 @default.
• W2141750554 hasConceptScore W2141750554C167734588 @default.
• W2141750554 hasConceptScore W2141750554C16930146 @default.
• W2141750554 hasConceptScore W2141750554C2777025900 @default.
• W2141750554 hasConceptScore W2141750554C502942594 @default.
• W2141750554 hasConceptScore W2141750554C71924100 @default.
• W2141750554 hasConceptScore W2141750554C86803240 @default.
• W2141750554 hasFunder F4320320719 @default.
• W2141750554 hasIssue "5" @default.
• W2141750554 hasLocation W21417505541 @default.
• W2141750554 hasLocation W21417505542 @default.
• W2141750554 hasOpenAccess W2141750554 @default.
• W2141750554 hasPrimaryLocation W21417505541 @default.
• W2141750554 hasRelatedWork W1966504330 @default.
• W2141750554 hasRelatedWork W1966775726 @default.
• W2141750554 hasRelatedWork W1979139803 @default.
• W2141750554 hasRelatedWork W1991560548 @default.

• next